| Code | 2030F | ||||||||||
| MA number | 68/0407/25-S | ||||||||||
| Product Form: | sus por 1x120 ml/3 g (fľ.skl.+adaptér, striekačka 5 ml, odmerka 20 ml) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Exeltis Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 01.01.2026 |
| Validity: | 01.01.2031 |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Equilion 25 mg_ml sus por_12_2025.pdf
|
| SPC: |
SPC_Equilion 25 mg_ml sus por_12_2025.pdf
|
| Safety feature | Yes |
| Data update: | 07.01.2026 |
